SBIR/STTR Research Award
OTHER FUNCTIONS: QUANTIFICATION OF BEHAVIORAL AND PHYSIOLOGICAL EFFECTS OF DRUGS USING A MOBILE SCALABLE DEVICE. N44DA-12-1206. SBIR PHASE II BASE AWARD.
Award amount
$1,000,000Program and phase
SBIR · Phase IIAward year
2012Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ADVANCED BRAIN MONITORING, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- CDQ7RHKMN5G7
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
The goal of this project is to develop a mobile, smartphone/tablet-based neurocognitive assessment that will provide a multifactoral (i.e., neural, physiological, performance) evaluation of cognitive functioning associated with impaired driving due to stimulant or depressant usage. The Mobile Alertness and Memory Profiler (M-AMP) will function as an essential tool for worldwide facilitation of epidemiological, comparative studies of drugged driving.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Characterizing neurocognitive deficits in post-acute sequelae of COVID-19
- Multi-site longitudinal Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)
- CANNABIS IMPAIRMENT DETECTION APPLICATION (CIDA) (T163). SBIR PHASE II. POP: 9/20/2019-9/19/2021. N44DA-19-1218.
- Neurophysiological Assessment of Information Environment Through a Multi-Sensor Platform
- Cannabis Impairment Detection Application (CIDA)
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
38 SBIR/STTR records share this UEI (1999–2025). Reported award amounts total $19,838,071. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, Department of Defense, Department of Homeland Security